Clear-cell renal cell carcinoma - A comprehensive review of agents used in the contemporary management of advanced/metastatic disease
Renal cell carcinoma represents the most common malignancy of the kidney and the majority of cases are categorized as clear cell carcinomas. The elucidation of the specific alterations in key molecular and metabolic pathways responsible for cancer development and progression have prompted the ratio...
Main Authors: | Stavros Gkolfinopoulos, Amanda Psyrri, Aristotelis Bamias |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2021-02-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | https://oncologyreviews.org/site/article/view/530 |
Similar Items
-
Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
by: Maria F. Czyzyk-Krzeska, et al.
Published: (2021-03-01) -
Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients
by: Jiwei Huang, et al.
Published: (2021-09-01) -
Spectrum of VHL mutations in clear cell renal cell carcinoma
by: N. N. Mazurenko, et al.
Published: (2020-11-01) -
Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma
by: Demin Fan, et al.
Published: (2020-06-01) -
Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment
by: Rohan Garje, et al.
Published: (2018-12-01)